BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 21/11/2014

FDA Announces Final Guidance for Biological Products: Human Blood and Blood Components

The FDA has released a final guidance document providing recommendations for manufacturers of licensed whole blood and blood components, including submission procedures and labeling changes, to finalize an approved biologics license application.

Source: Federal Register — Food and Drug AdministrationOpen original release →